The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies
Open accessAbstract
NLCs have provoked the incessant impulsion for the development of safe and valuable drug delivery systems owing to their exceptional physicochemical and then biocompatible characteristics. Throughout the earlier period, a lot of studies recounting NLCs based formulations have been noticeably increased. They are binary system which contains both solid and liquid lipids aiming to produce less ordered lipidic core. Their constituents particularly influence the physicochemical properties and effectiveness of the final product. NLCs can be fabricated by different techniques which are classified according to consumed energy. More utilization NLCs is essential due to overcome barriers surrounded by the technological procedure of lipid-based nanocarriers' formulation and increased information of the core mechanisms of their transport via various routes of administration. They can be used in different applications and by different routes such as oral, cutaneous, ocular and pulmonary. This review article seeks to present an overview on the existing situation of the art of NLCs for future clinics through exposition of their applications which shall foster their lucid use. The reported records evidently demonstrate the promise of NLCs for innovate therapeutic applications in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products
Pardeike, J., Hommoss, A., & Müller, R. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.003 · Cited by 1,478
Mehnert, W., & Mäder, K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.021 · Cited by 981
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
Das, S., & Chaudhury, A. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-010-9563-0 · Cited by 838
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 802
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 769
Nanostructured lipid carriers (NLC) in cosmetic dermal products☆
MULLER, R., PETERSEN, R., HOMMOSS, A., & PARDEIKE, J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.012 · Cited by 700
Nanoparticles for drug delivery to the lungs
Sung, J. C., Pulliam, B. L., & Edwards, D. A. (2007) · Trends in Biotechnology · doi:10.1016/j.tibtech.2007.09.005 · Cited by 643
Nanostructured lipid carriers for site-specific drug delivery
Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 619
Hauss, D. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.006 · Cited by 595
Overcoming the Stratum Corneum: The Modulation of Skin Penetration
Trommer, H., & Neubert, R. H. H. (2006) · Skin Pharmacology and Physiology · doi:10.1159/000091978 · Cited by 572
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
Kreuter, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.008 · Cited by 554
20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications
H. Muller, R., Shegokar, R., & M. Keck, C. (2011) · Current Drug Discovery Technologies · doi:10.2174/157016311796799062 · Cited by 544
Fang, J.-Y., Fang, C.-L., Liu, C.-H., & Su, Y.-H. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.008 · Cited by 518
Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier
Salvi, V. R., & Pawar, P. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.02.017 · Cited by 456
Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery
Battaglia, L., & Gallarate, M. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.673278 · Cited by 400
Applications of nanoparticles in ophthalmology
Diebold, Y., & Calonge, M. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.08.002 · Cited by 392
Reis, S., Neves, Lúcio, Martins, & Lima (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s37840 · Cited by 368
Teeranachaideekul, V., Souto, E. B., Junyaprasert, V. B., & Müller, R. H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.015 · Cited by 323
Zhuang, C.-Y., Li, N., Wang, M., Zhang, X.-N., Pan, W.-S., Peng, J.-J., Pan, Y.-S., & Tang, X. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.005 · Cited by 318
MEASUREMENT OF TOTAL LUNG DEPOSITION OF INHALED ULTRAFINE PARTICLES IN HEALTHY MEN AND WOMEN
Peter A. Jaques, C. S. K. (2000) · Inhalation Toxicology · doi:10.1080/08958370050085156 · Cited by 287
Solid lipid nanoparticles: an oral bioavailability enhancer vehicle
Harde, H., Das, M., & Jain, S. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.604311 · Cited by 281
Lipid nanoparticles for prolonged topical delivery: An in vitro and in vivo investigation
Puglia, C., Blasi, P., Rizza, L., Schoubben, A., Bonina, F., Rossi, C., & Ricci, M. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.045 · Cited by 266
Quercetin-nanostructured lipid carriers: Characteristics and anti-breast cancer activities in vitro
Sun, M., Nie, S., Pan, X., Zhang, R., Fan, Z., & Wang, S. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.08.032 · Cited by 263
Tiwari, R., & Pathak, K. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.044 · Cited by 261
Patlolla, R. R., Chougule, M., Patel, A. R., Jackson, T., Tata, P. N. V., & Singh, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.006 · Cited by 250
TEERANACHAIDEEKUL, V, MULLER, R., & JUNYAPRASERT, V (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.022 · Cited by 250
Development of a Quercetin-loaded nanostructured lipid carrier formulation for topical delivery
Chen-yu, G., Chun-fen, Y., Qi-lu, L., Qi, T., Yan-wei, X., Wei-na, L., & Guang-xi, Z. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.042 · Cited by 247
pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease
Beloqui, A., Coco, R., Memvanga, P. B., Ucakar, B., des Rieux, A., & Préat, V. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.07.009 · Cited by 240
Alveolar clearance and the role of the pulmonary lymphatics.
Lauweryns, J. M., & Baert, J. H. (1977) · PubMed · doi:10.1164/arrd.1977.115.4.625 · Cited by 233
Shah, N. V., Seth, A. K., Balaraman, R., Aundhia, C. J., Maheshwari, R. A., & Parmar, G. R. (2016) · Journal of Advanced Research · doi:10.1016/j.jare.2016.03.002 · Cited by 223
Pardeike, J., Weber, S., Haber, T., Wagner, J., Zarfl, H. P., Plank, H., & Zimmer, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.040 · Cited by 216
Lipid Nanoparticles: Effect on Bioavailability and Pharmacokinetic Changes
Souto, E. B., & Müller, R. H. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_4 · Cited by 210
Beloqui, A., Solins, M. N., Gascn, A. R., del Pozo-Rodrguez, A., des Rieux, A., & Prat, V. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.021 · Cited by 208
Oral Bioavailability: Issues and Solutions via Nanoformulations
Pathak, K., & Raghuvanshi, S. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0242-x · Cited by 188
Advances in lipid-based colloid systems as drug carrier for topic delivery
Zhai, Y., & Zhai, G. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.054 · Cited by 186
Mendes, A. I., Silva, A. C., Catita, J. A. M., Cerqueira, F., Gabriel, C., & Lopes, C. M. (2013) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.05.041 · Cited by 181
Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery
Gonzalez-Mira, E., Egea, M. A., Souto, E. B., Calpena, A. C., & García, M. L. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/4/045101 · Cited by 180
Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery
Shen, J., Wang, Y., Ping, Q., Xiao, Y., & Huang, X. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.021 · Cited by 179
Sánchez-López, E., Espina, M., Doktorovova, S., Souto, E. B., & García, M. L. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.009 · Cited by 172
Q10-loaded NLC versus nanoemulsions: Stability, rheology and in vitro skin permeation
Junyaprasert, V. B., Teeranachaideekul, V., Souto, E. B., Boonme, P., & Müller, R. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.05.020 · Cited by 163
Gupta, M., & Vyas, S. P. (2012) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2012.01.006 · Cited by 160
Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery
Fang, J. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s9155 · Cited by 159
Shahgaldian, P., Da Silva, E., Coleman, A. W., Rather, B., & Zaworotko, M. J. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00639-7 · Cited by 158
Arora, R., Katiyar, S. S., Kushwah, V., & Jain, S. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1264386 · Cited by 157
Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis
Beloqui, A., Coco, R., Alhouayek, M., Solinís, M. Á., Rodríguez‐Gascón, A., Muccioli, G. G., & Véronique Préat, A. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.017 · Cited by 155
Tran, T. H., Ramasamy, T., Truong, D. H., Choi, H., Yong, C. S., & Kim, J. O. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0175-y · Cited by 153
Zhang, T., Chen, J., Zhang, Y., Shen, Q., & Pan, W. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.04.005 · Cited by 152
Altering the immune response with lipid-based nanoparticles
Landesman‐Milo, D., & Peer, D. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.034 · Cited by 148
Fathi, H. A., Allam, A., Elsabahy, M., Fetih, G. N., & El‐Badry, M. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.11.064 · Cited by 134
Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy
del Pozo‐Rodríguez, A., Solinís, M. Á., Rodríguez‐Gascón, A., & Pedraz, J. L. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.015 · Cited by 129
Pradhan, M., Singh, D., Murthy, S. N., & Singh, M. R. (2015) · Steroids · doi:10.1016/j.steroids.2015.05.012 · Cited by 125
Mendes, I. T., Ruela, A. L. M., Carvalho, F. C., Freitas, J. T. J., Bonfílio, R., & Pereira, G. R. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.02.007 · Cited by 125
Nanostructured lipid carriers for the topical delivery of tretinoin
Ghate, V., Lewis, S. A., Prabhu, P., Dubey, A., & Patel, N. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.07.026 · Cited by 116
Gainza, G., Celdran‐Bonafonte, D., Moreno, B., Aguirre, J. J., Gutiérrez, F. B., Villullas, S., Pedraz, J. L., Igartua, M., & Hernández, R. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.033 · Cited by 114
Khan, N., Shah, F. A., Rana, I., Ansari, M. M., Din, F. U., Rizvi, S. Z. H., Aman, W., Lee, G.-Y., Lee, E.-S., Kim, J., et al. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119033 · Cited by 112
Natural lipids-based NLC containing lidocaine: from pre-formulation to in vivo studies
Ribeiro, L. N. D. M., Breitkreitz, M. C., Guilherme, V. A., da Silva, G. H. R., Couto, V. M., Castro, S. R., PAULA, B. O. D., Machado, D., & de Paula, E. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.05.060 · Cited by 110
Montelukast-loaded nanostructured lipid carriers: Part I Oral bioavailability improvement
Patil-Gadhe, A., & Pokharkar, V. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.05.019 · Cited by 107
Liu, R., Liu, Z., Zhang, C., & Zhang, B. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23251 · Cited by 107
Beloqui, A., Memvanga, P. B., Coco, R., Reimóndez-Troitiño, S., Alhouayek, M., Muccioli, G. G., Alonso, M. J., Csaba, N., de la Fuente, M., & Véronique Préat, A. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.03.038 · Cited by 105
Gu, Y., Tang, X., Yang, M., Yang, D., & Liu, J. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.11.024 · Cited by 102
Lakhani, P. M., Patil, A., Wu, K.-W., Sweeney, C., Tripathi, S., Avula, B., Taskar, P., Khan, S. I., & Majumdar, S. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118771 · Cited by 99
Pardeike, J., Schwabe, K., & Müller, R. H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.007 · Cited by 96
Thapa, C., Ahad, A., Aqil, M., Imam, S. S., & Sultana, Y. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.02.003 · Cited by 92
Song, X. C., Lin, Q., Guo, L. H., Fu, Y. S., Han, J., Ke, H., Sun, X., Gong, T., & Zhang, Z. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1572-3 · Cited by 90
Jyoti, K., Kaur, K., Pandey, R. S., Jain, U. K., Chandra, R., & Madan, J. (2015) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2014.12.092 · Cited by 90
Vieira, A. C. C., Magalhães, J., Rocha, S., Cardoso, M. S., Santos, S. G., Borges, M. C., Pinheiro, M., & Reis, S. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0248 · Cited by 89
Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability
Kaithwas, V., Dora, C. P., Kushwah, V., & Jain, S. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.03.006 · Cited by 86
Shete, H. K., Chatterjee, S., De, A., & Patravale, V. B. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.036 · Cited by 82
Noor, N. M., Sheikh, K., Somavarapu, S., & Taylor, K. M. G. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.04.012 · Cited by 82
Zhou, X., Zhang, X., Ye, Y., Zhang, T., Wang, H., Ma, Z., & Wu, B. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.068 · Cited by 78
Sanna, V., Caria, G. P., & Mariani, A. (2010) · Powder Technology · doi:10.1016/j.powtec.2010.02.035 · Cited by 77
Fang, J., Hwang, T., Fang, C.-L., & Chiu, H.-C. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00086-3 · Cited by 77
Enhanced oral bioavailability of an antipsychotic drug through nanostructured lipid carriers
Natarajan, J., Hingarh, P. K., Radhakrishnan, A., Selvaraj, J., Anbarasan, A., Sankaran, S., & Nagaraju, G. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.01.121 · Cited by 77
Chanburee, S., & Tiyaboonchai, W. (2016) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2016.1257020 · Cited by 72
Balguri, S. P., Adelli, G. R., Janga, K. Y., Bhagav, P., & Majumdar, S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.042 · Cited by 72
Huguet-Casquero, A., Xu, Y., Gaínza, E., Pedraz, J. L., & Beloqui, A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119515 · Cited by 70
Pardeike, J., Weber, S., Zarfl, H. P., Pagitz, M., & Zimmer, A. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.07.018 · Cited by 68
Beloqui, A., Solinís, M. Á., Delgado, A., Évora, C., del Pozo‐Rodríguez, A., & Rodríguez‐Gascón, A. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.01.029 · Cited by 63
Nafee, N. A., Makled, S., & Boraie, N. A. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.10.003 · Cited by 63
Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers
Zhou, J. P., & Daxin, Z. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s90016 · Cited by 60
Beloqui, A., Solinís, M. Á., Delgado, A., Évora, C., Isla, A., & Rodríguez‐Gascón, A. (2013) · Journal of Microencapsulation · doi:10.3109/02652048.2013.788090 · Cited by 60
Zhao, C., Zhang, J., Hu, H., Qiao, M., Chen, D., Zhao, X., & Yang, C. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.02.004 · Cited by 60
Kalapos, M. P. (2002) · Adverse Drug Reactions and Toxicological Reviews · doi:10.1007/bf03256188 · Cited by 59
Khan, S., Yar, M. S., Fazil, M., Hassan, M. Q., Baboota, S., & Ali, J. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.011 · Cited by 58
Elmowafy, M., Shalaby, K., Ali, H. M., Alruwaili, N. K., Salama, A., Ibrahim, M. F., Akl, M. A., & Ahmed, T. A. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118781 · Cited by 57
Self-citationBrugè, F., Damiani, E., Marcheggiani, F., Offerta, A., Puglia, C., & Tiano, L. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.09.033 · Cited by 56
Tian, B., Luo, Q., Song, S., Liu, D., Pan, H., Zhang, W., He, L., Shi-lin, M., Yang, X., & Pan, W. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22813 · Cited by 55
Liang, Y., Tian, B., Zhang, J., Li, K., Wang, L., Han, J., & Wu, Z. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s121262 · Cited by 55
Lacatusu, I., Istrati, D., Bordei, N., Popescu, M., Seciu‐Grama, A., Panteli, L. M., & Badea, N. M. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110412 · Cited by 54
Promises of Nanotechnology for Drug Delivery to Brain in Neurodegenerative Diseases
Baratchi, S., Kanwar, R. K., Khoshmanesh, K., Punj, V., Chauhan, A., Matta, H., Parratt, A. J., Krishnakumar, S., Sun, X., Sahoo, S. K., et al. (2009) · Current Nanoscience · doi:10.2174/157341309787314665 · Cited by 50
Li, N., Weng, D., Wang, S., Zhang, Y., Chen, S., Yin, Z.-F., Zhai, J., Scoble, J. A., Williams, C. C., Chen, T., et al. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1402217 · Cited by 50
Chaiyana, W., Anuchapreeda, S., Somwongin, S., Marsup, P., Lee, K., Lin, W., & Lue, S.-C. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040309 · Cited by 43
Arsenie, L. V., Lăcătuşu, I., Oprea, O., Bordei, N., Bacalum, M., & Badea, N. M. (2020) · Industrial Crops and Products · doi:10.1016/j.indcrop.2020.112658 · Cited by 42
Zheng, K., Zou, A., Yang, X., Liu, F., Xia, Q., Ye, R., & Mu, B. (2012) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2012.11.006 · Cited by 41
Tazehjani, D. A. J., Farahpour, M. R., & Hamishehkar, H. (2020) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2020.125748 · Cited by 40
Li, J., Tan, G., Cheng, B., Liu, D., & Pan, W. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.08.013 · Cited by 38
Assasy, A. E.-H. I. E., Younes, N. F., & Makhlouf, A. I. A. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-018-1283-x · Cited by 38
Tian, Z., Yi, Y., Yuan, H., Han, J., Zhang, X., Xie, Y., Lü, Y., Qi, J., & Wu, W. (2013) · Powder Technology · doi:10.1016/j.powtec.2013.07.010 · Cited by 37
Pokharkar, V., Patil-Gadhe, A., & Kaur, G. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0342-8 · Cited by 36
Muchow, M., Muchow, M., Schmitz, E. I., Despatova, N., Maincent, P., & Müller, R. H. (2009) · Die Pharmazie · doi:10.31083/ph.2009.9084 · Cited by 26
Amorndoljai, P., Taneepanichskul, S., Niempoog, S., & Nimmannit, U. (2017) · PubMed · Cited by 24
Cited by
Overcoming skin barriers through advanced transdermal drug delivery approaches
Phatale, V., Vaiphei, K. K., Jha, S., Patil, D., Agrawal, M., & Alexander, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.025 · Cited by 482
Advancements in nanoparticle-based treatment approaches for skin cancer therapy
Zeng, L., Gowda, B. H. J., Ahmed, M. G., Abourehab, M. A. S., Chen, Z.-S., Zhang, C., Li, J., & Kesharwani, P. (2023) · Molecular Cancer · doi:10.1186/s12943-022-01708-4 · Cited by 365
Desai, N., Rana, D., Patel, M., Bajwa, N., Prasad, R., & Vora, L. K. (2025) · Small · doi:10.1002/smll.202502315 · Cited by 295
Khan, S., Sharma, A., & Jain, V. (2023) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2023.056 · Cited by 259
Kochman, U., Sitka, H., Kuźniar, J., Czaja, M., Kozubek, P., Beszłej, J. A., & Leszek, J. (2026) · Molecular Neurobiology · doi:10.1007/s12035-025-05417-z · Cited by 60
Metadata
- Authors
- Elmowafy, M., & Al-Sanea, M. M.
- Venue
- Saudi Pharmaceutical Journal
- Published
- 2021-09
- Volume
- 29
- Issue
- 9
- Pages
- 999-1012
- ISSN
- 1319-0164 (ISSN-L)
- OpenAlex
- W3186211590
- Cited by
- 382
- References
- 104
- FWCI
- 16.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.